Overall, ongoing research is crucial to fully elucidate the relationship between AAT heterozygous mutations, early-life wheezing, and the risk of developing COPD, ultimately contributing to better prevention, diagnosis, and treatment strategies. The gene discussed is SERPINA1; the disease is chronic obstructive pulmonary disease.